Business Wire

Belkin Achieves Carbon Neutrality in Scope 1 and Scope 2 Emissions

Share

The company’s 2024 Impact Report showcases bold sustainability progress and innovation

Belkin, a leading consumer electronics brand for 40 years, today published its 2024 Impact Report, announcing its milestone achievement of carbon neutrality in scope 1 and scope 2 emissions, and underscoring its commitment to sustainability and corporate responsibility. With bold progress in carbon reduction and sustainable product design, Belkin remains steadfast in its commitment to finding more responsible ways to build products that enhance lives while preserving the planet for future generations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421326773/en/

Belkin achieves carbon neutrality in scope 1 and scope 2 emissions

“Belkin recently surpassed a monumental milestone: over 1 billion products sold globally. As we reflect on this achievement, we recognize that with scale comes a profound responsibility – to our customers, to the planet, and to future generations,” said Steven Malony, CEO of Belkin. “As we reflect on our 2024 Impact Report, we recognize the progress we’ve made and the work still ahead. We are actively transitioning to post-consumer recycled (PCR) materials across our product lines, using 100% plastic-free packaging, and investing in long-term sustainability strategies to achieve our larger goals of carbon neutrality across our entire business by 2030. Our mission goes beyond creating accessories that empower people to get more life out of every single day – it’s about driving positive change for the planet and its people.”

In the last 12 months, on its journey to carbon neutrality in all scopes by 2030 and in line with its commitment to the UN Sustainable Development Goals, Belkin has achieved:

Climate action (UN Goal 13)

  • Carbon neutrality in direct and purchased emissions (Scopes 1 and 2 emissions)
  • 1,890 metric tons of CO2e reduced on product level (Scope 3 emissions)

Responsible consumption and production (UN Goal 12)

  • 89% reduction in single use plastic packaging (surpassing our 25% reduction goal by 2025)
  • 210 metric tons of virgin plastics replaced from 8.8M PCR products sold
  • 2,183 metric tons cumulative plastic savings since 2019 (this is the equivalent of 114M water bottles saved)
  • Funding the responsible recycling of:
    • 28,445 metric tons of electrical and electronic devices
    • 11,463 metric tons of packaging
    • 1,358 metric tons of batteries

Made with recycled materials

Two years since introducing its transition to using 72-75% post-consumer recycled (PCR) materials in its products, Belkin has transitioned over 359 products and has replaced 432 metric tons of virgin plastics with PCR materials. This year, several of Belkin’s most popular chargers and cables will receive updated product housing materials that consist of 85-90% PCR and will be certified by the Global Recycling Standard and sold in plastic-free packaging. This initiative is estimated to reduce CO2-eq emissions for these product housing materials by up to 85%.

Award-winning initiatives

Belkin is proud to announce an important achievement in its sustainability journey: receiving a Silver Medal rating from EcoVadis, the globally recognized leader in sustainability ratings. This recognition reflects the company’s ongoing dedication to responsible business practices and positions Belkin among the top-performing companies in the consumer electronics sector evaluated by EcoVadis. Belkin’s overall score ranks in the top 15% globally (91st Percentile) among companies in our industry assessed by EcoVadis.

Shaping a more responsible future

Looking ahead, Belkin remains dedicated to achieving carbon neutrality in all scopes by 2030 and continuously refining its strategy to build products more responsibly. The company is actively investing in circular design principles and exploring innovative ways to further reduce environmental impact without compromising performance or quality.

For more information on Belkin’s sustainability initiatives, visit www.belkin.com/company/sustainability/.

About Belkin

Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From our humble beginnings in a Southern California garage in 1983, Belkin has become a diverse, global technology company. We remain forever inspired by the planet we live on, and the connection between people and technology.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250421326773/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye